Skip to Main content Skip to Navigation
New interface
Journal articles

Evaluation of a human iPSC-derived BBB model for repeated dose toxicity testing with cyclosporine A as model compound

Abstract : The blood-brain barrier (BBB) is a highly restrictive barrier that preserves central nervous system homeostasis and ensures optimal brain functioning. Using BBB cell assays makes it possible to investigate whether a compound is likely to compromise BBBs functionality, thereby probably resulting in neurotoxicity. Recently, several protocols to obtain human brain-like endothelial cells (BLECs) from induced pluripotent stem cells (iPSCs) have been reported. Within the framework of the European MSCA-ITN in3 project, we explored the possibility to use an iPSC-derived BBB model to assess the effects of repeated dose treatment with chemicals, using Cyclosporine A (CsA) as a model compound. The BLECs were found to exhibit important BBB characteristics up to 15 days after the end of the differentiation and could be used to assess the effects of repeated dose treatment. Although BLECs were still undergoing transcriptional changes over time, a targeted transcriptome analysis (TempO-Seq) indicated a time and concentration dependent activation of ATF4, XBP1, Nrf2 and p53 stress response pathways under CsA treatment. Taken together, these results demonstrate that this iPSC-derived BBB model and iPSC-derived models in general hold great potential to study the effects of repeated dose exposure with chemicals, allowing personalized and patient-specific studies in the future.
Document type :
Journal articles
Complete list of metadata
Contributor : Virginie Justin-Labonne Connect in order to contact the contributor
Submitted on : Monday, July 19, 2021 - 2:42:32 PM
Last modification on : Friday, January 21, 2022 - 3:30:02 AM
Long-term archiving on: : Wednesday, October 20, 2021 - 6:50:43 PM


Wellens et al., 2021.pdf
Publication funded by an institution


Distributed under a Creative Commons Attribution - NonCommercial - NoDerivatives 4.0 International License




Sara Wellens, Lucie Dehouck, Vidya Chandrasekaran, Pranika Singh, Rodrigo Azevedo Loiola, et al.. Evaluation of a human iPSC-derived BBB model for repeated dose toxicity testing with cyclosporine A as model compound. Toxicology in Vitro, 2021, 73, pp.105112. ⟨10.1016/j.tiv.2021.105112⟩. ⟨hal-03185595⟩



Record views


Files downloads